News Tag: COVID-19
-
Digital health researchers explore COVID-19’s prolonged effects
As part of Scripps Research’s landmark DETECT study, scientists are examining physiological and behavioral changes that often last months after a COVID-19 infection.
-
Scripps Research collaborates with The Rockefeller Foundation on digital COVID-19 surveillance, pandemic preparedness
A grant from the New York-based foundation will fuel expansion of DETECT, Scripps Research’s sensor-based study for real-time digital detection of viral illness.
-
Extensive study identifies over a dozen existing drugs as potential COVID-19 therapies
FDA-approved drugs or experimental drugs with ample health data could be rapidly tested in humans for treatment of COVID-19.
-
Versatile coronavirus antibody may be starting point for broader-acting vaccines
Scientists from Scripps Research investigated how the immune system’s previous exposure to cold-causing coronaviruses impact immune response to COVID-19.
-
Scientists reveal structural details of how SARS-CoV-2 variants escape immune response
The findings provide direction for future vaccines or therapies that may offer broader protection against variants.
-
B.1.1.7 variant of COVID-19 virus spreading rapidly in United States
A genetic analysis of virus samples suggests that the UK-originating variant, which is 40-50 percent more transmissible, entered the country in late November 2020.
-
Experimental COVID-19 vaccine appears to work well against variants of concern
Results from studies in mice suggest the protein-based vaccine could potentially serve as a booster shot to cover emerging COVID-19 variants.
-
Experimental COVID-19 vaccine takes novel approach to boosting immune response
The protein-based vaccine delivers particles that mimic the shape of a whole virus; early tests in mice suggest it also may work against variants of SARS-CoV-2.
-
Experts call for streamlined lab tests of SARS-CoV-2 variants to spot worrisome features
Rapid genetic sequencing of COVID-19 virus samples isn’t enough; standardized lab tests are needed to understand potential mutations that may boost infectiousness or enable immune evasion.
-
Scripps Research tracks prevalence of new COVID-19 variants with daily reports on Outbreak.info
To drive global research efforts, the Center for Viral Systems Biology at Scripps Research is tracking the prevalence of new variants of SARS-CoV-2 and making this information publicly available.